Figure 3.

Durability of serum neutralizing activity against wildtype SARS-CoV-2. (A) Serum neutralization against wildtype SARS-CoV-2 at different time points post-vaccination. Each dot represents a donor: uninfected unvaccinated NC donors (gray), and BBIBP-CorV- (orange), WIBP-CorV- (blue), and CoronaVac-vaccinated donors (purple). For each donor, x-axis represents the number of days after primary vaccination for blood donation; meanwhile, the y-axis shows the measured serum neutralizing titer (NT₅₀ value) against wildtype SARS-CoV-2 (square). Three different time periods are separated by vertical dashed lines: 0~100 days, 100~150 days, and >150 days after 2nd-dose inactivated vaccination. The NT₅₀ values of all NC serum samples (gray square) are below 130 (horizontal dashed line) and the percentages of the donors with serum neutralizing titer higher than 130 are shown within each group. (B) Comparison of serum neutralizing titers against wildtype SARS-CoV-2 for different groups of donors. The p-values are calculated using Kruskal–Wallis test. (C,D) Correlations between the days post-vaccination (x-axis) and the log(NT₅₀ against wildtype SARS-CoV-2) of BBIBP-CorV (C) or CoronaVac (D) (y-axis).